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RECENT DEVELOPMENTS 
TORTS-STRICT LIABILITY-A Hospital Is Strictly 
Liable for Transfusions of Hepatitis-Infected 
Blood-Cunningham v. MacNeal 
Memorial Hospital* 
While undergoing treatment at MacNeal Memorial Hospital 
in Chicago, Illinois, Mrs. Frances Cunningham was given several 
transfusions of whole blood. Apparently, some of the blood contained 
the virus of homologous serum hepatitis1 because Mrs. Cunningham 
was affiicted with that disease and forced to lengthen her stay in the 
hospital. She sued the hospital for 50,000 dollars on the allegation 
that the blood used in the transfusions "was defective and in an un-
reasonably dangerous condition."2 The hospital defended on the 
ground that Mrs. Cunningham's action was based on a theory of 
strict liability inapposite to blood transfusion cases. The trial court 
agreed and dismissed the complaint, but the appellate court reversed, 
holding that blood is a product subject to the doctrine of strict 
liability when sold.3 Significantly, however, the appellate court de-
clined to determine whether the blood could have been made safe.~ 
Thus, the appellate court left open the issue whether the hospital 
might escape liability if it could show that the blood was incapable 
of being rendered safe. 5 
• 47 Ill. 2d 443, 266 N.E.2d 897 (1970) [hereinafter principal case]. The appellate 
court decision, reversing a judgment on the pleadings for the defendant, is reported 
at 113 Ill. App. 2d 74, 251 N.E.2d 733 (1969). 
I. Hepatitis is an inflammation of the liver. I ATIORNEY'S DICTIONARY OF MEDICINE 
401 (1969). Homologous serum hepatitis is caused by a parenteral (through the blood 
stream) introduction of a filterable agent known as virus B. Its effects can vary from 
virtually none to severe illness and death. 2 R. GRAY, ATIORNEY'S TEXTBOOK OF MEDI-
CINE ,i,i 38.30-.37 (3d ed. 1970); J. SCHMIDT, ATIORNEY's DICTIONARY OF MEDICINE 
AND WORD FINDER 357 (1965); C. TABER, TABER'S CYCLOPEDIC MEDICAL DICTIONARY, 
H-28 (9th ed. 1963). The condition is also known as serum hepatitis, homologous serum 
jaundice, serum jaundice, inoculation jaundice, transfusion jaundice, post-vaccinal 
hepatitis, post-vaccinal jaundice, and late arsphenamine jaundice. See J. SCHMIDT, 
supra at 357; M. SPELLBERG, DISEASES OF THE LivER 256 (1954). Serum hepatitis is 
clinically and pathologically indistinguishable from infectious hepatitis, but the latter 
disease is contracted through the mouth and intestinal tract and has a shorter incuba-
tion period (10-40 days, as opposed to 45-160 days for serum hepatitis). M. SPELLBERG, 
supra at 257. Serum hepatitis can also be transmitted by blood on any instrument that 
pierces the skin. There are some recent indications that hepatitis may be spread by 
direct and indirect contact as well as through transfusions and contaminated needles. 
See N.Y. Times, Feb. 7, 1971, § I, at 70, cols. 3-4. 
2. 113 Ill. App. 2d at 75-76, 251 N.E.2d at 733-34. The substantive portions of the 
plaintiff's complaint are reproduced in the appellate court opinion. 
3. 113 Ill. App. 2d at 85, 251 N.E.2d at 738. 
4. Since the case was before the appellate court on appeal from a judgment on the 
pleadings, the appellate court properly held that a decision on this question would have 
been premature. 113 Ill. App. 2d at 86, 251 N.E.2d at 739. 
5. The appellate court was apparently implying that a possible defense could be 
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All such lingering doubts, however, were put to rest by the 
Illinois supreme court. In an unprecedented decision based primarily 
upon the Restatement (Second) of Torts section 402A,6 it agreed 
with the appellate court that blood is a product and that a transfusion 
is a sale within the meaning of the Restatement. But the supreme 
court went further and announced that the "unavoidably unsafe" 
exception of comment k7 to the Restatement could not provide the 
hospital with a valid defense. Comment k, according to the supreme 
court," ... relates only to products which are not impure and which, 
even if properly prepared, inherently involve substantial risk of 
injury to the user.''8 Since hepatitis-infected blood is by definition 
impure, comment k could have no bearing on the case. By reading 
the comment so narrowly, the Illinois supreme court imposed strict 
liability on hospitals for transfusions of blood carrying the serum 
hepatitis virus. This Recent Development will briefly trace the de-
velopment of hospital liability for transfusions of hepatitis-infected 
blood and will analyze both the impact of Cunningham on that area 
of the law and the correctness of the Cunningham decision. 
raised based on RESTATEMENT (SECOND) OF TORTS § 402A, comment k at 353-54 (1965) 
[hereinafter RESTATEMENT]. See note 7 infra for the full text of comment k. 
6. Section 402A provides: 
Special Liability of Seller of Product for Physical Harm to User or Consumer 
(1) One who sells any product in a defective condition unreasonably dangerous to 
the user or consumer or to his property is subject to liability for physical harm 
thereby caused to the ultimate user or consumer, or to his property, if 
(a) the seller is engaged in the business of selling such a product, and 
(b) it is expected to and does reach the user or consumer without substantial 
change in the condition in which it is sold. 
(2) The rule stated in Subsection (1) applies although 
(a) the seller has exercised all possible care in the preparation and sale of his 
product, and 
(b) the user or consumer has not bought the product from or entered into any 
contractual relation with the seller. 
RESTATEMENT § 402A, at 347-48 (emphasis added). 
7. RESTATEMENT § 402A, comment k at 353-54 provides in full: 
Unavoidably unsafe products. There are some products which, in the present state 
of human knowledge, are quite incapable of being made safe for their intended 
and ordinary use. These are especially common in the field of drugs. An out-
standing example is the vaccine for the Pasteur treatment of rabies, which not 
uncommonly leads to very serious and damaging consequences when it is injected. 
Since the disease itself invariably leads to a dreadful death, both the marketing 
and the use of the vaccine are fully justified, notwithstanding the unavoidable high 
degree of risk which they involve. Such a product, properly prepared, and accom-
panied by proper directions and warning, is not defective, nor is it unreasonably 
dangerous. The same is true of many other drugs, vaccines, and the like, many of 
which for this very reason cannot legally be sold except to physicians, or under 
the prescription of a physician. It is also true in particular of many new or experi-
mental drugs as to which, because of lack of time and opportunity for sufficient 
medical experience, there can be no assurance of safety, or even perhaps of purity 
of ingredients, but such experience as there is justifies the marketing and use of 
the drug notwithstanding a medically recognizable risk. The seller of such products, 
again with the qualification that they are properly prepared and marketed, and 
proper warning is given, where the situation calls for it, is not to be held to strict 
liability for unfortunate consequences attending their use, merely because he has 
undertaken to supply the public with an apparently useful and desirable product, 
attended with a known but apparently reasonable risk. 
8. 47 m. 2d at 456, 266 N.E.2d at 904. 
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The disease that allegedly caused Mrs. Cunningham her anguish 
has afflicted man for centuries,9 but not until the 1940's was it dis-
covered that the causative virus could be introduced by the trans-
fusion of blood.10 While hepatitis is not the only disease that can 
be transmitted by blood transfusion, 11 it does represent one of the 
most serious risks associated with this treatment because of its fre-
quency of occurrence, 12 its undetectability, 13 and the present lack of 
vaccines and other satisfactory methods of prevention.14 
9. For a succinct history of serum hepatitis, see Butterich &: Wilson, Serum Hepatitis 
-A Historical Perspective and Current Progress, 36 U. MICH. MED. CENTER J. 67 (1970) 
10. See R. GRAY, supra note 1, ,r 38.35. 
11. Other diseases that can be transmitted parenterally include malaria, syphilis, 
measles, and influenza. See Wiener, Medicolegal Aspects of Blood Transfusions, 151 
J.A.M.A. 1435, 1438 (1953). These diseases, however, do not pose the serious threat that 
hepatitis does because they are readily detected when proper procedures are employed. 
See Van Wormer, Blood Transfusion Therapy, Pitfalls and Practice, MED. TRIAL TECH. 
Q., June, 1968, at 57-60. 
12. Although there is agreement that the frequency of blood transfusions and the 
incidence of serum hepatitis resulting therefrom are such that the disease presents a 
very serious medical problem, the estimates demonstrate considerable divergence of 
opinion on what the contractual rate actually is. Thus one encounters contentions rang• 
ing from an infection rate of 3% in whole blood, R. GRAY, supra note I, ,r 38.35, to 
one of .2%, Wiener, Prevention of Accidents in Blood Transfusions, 156 J.A.M.A. 1301, 
1305 (1954). Others include .33%, 9 TRAUMATIC MEDICINE &: SURGERY FOR THE ATTORNEY 
110 (1963); .25% to 3%, VanMeveren, The Extension of Liability to Service Contracts-
Emphasizing the Furnishing of Unfit Blood for Transfusion, 6 AM. Bus. L.J. 517, 518 
(1968); and .1 to 1% "at most," Butterich &: Wilson, supra note 9, at 67. With the use 
of blood plasma the rate jumps to around 12%, VanMeveren, supra at 518. 
The hepatitis-related fatality figures similarly show a difference of opinion, with 
some commentators asserting a rate of 3½% of those contacting the virus, Wiener, 
supra note 11, at 1037. Others estimate 6%, 9 TRAUMATIC MEDICINE&: SURGERY FOR THE 
ATTORNEY, supra at 110; and 12%, Chalmers, Koff &: Grady, A Note on Fatality in 
Serum Hepatitis, 49 GASTRoENTEROLOGY 23 (1965). The last cited article is the most 
complete study of the subject of those listed. In translating these percentages into num-
bers of patients affected one recent article summarized as follows: 
Several studies on representative numbers of recipients of blood transfusions lead 
to estimates of 30,000 cases of serious overt illness and 1,500 to 3,000 deaths from 
transfusion-associated viral hepatitis [meaning in this instance serum hepatitis] each 
year in the United States. However, there is evidence that the reporting of the 
overt disease is incomplete and that the incidences of illness and mortality that it 
causes may be much higher. Also, it is estimated that the ratio of subclinical hepa-
titis cases associated with transfusion to cases of the overt disease may be as high 
as 5:1. 
Panel of the Committee on Plasma and Plasma Substitutes of the Division of Medical 
Sciences, Statement on Laboratory Screening Tests for Identifying Carriers of 'Viral 
Hepatitis in Bloodbanking and Transfusion Services, IO TRANSFUSION 1-2 (1970) [here• 
inaner TRANSFUSION]. 
All of the above statistics are, of course, subject to the limitations of the studies that 
produced them, and this in part may explain the differences. Specifically, age of the 
recipient, source of the blood, number of transfusions given, and procedures employed 
by blood bank and hospital can and do significantly affect the findings. See generally 
Chalmers, Koff &: Grady, supra. 
13. See note 16 infra. 
14. Mosely &: Galambos, 'Viral Hepatitis in DISEASES OF THE LivER 410 (L. Schiff 3d 
ed. 1969) surmise at 468 that "[t]ransfusion-associated hepatitis, at least in relation 
to whole blood and some blood products, cannot be eliminated." Furthermore, "[f]or 
the foreseeable future ••• no vaccine is likely to be available against ••• serum hepa-
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Although there has been some literature heralding possible new 
effective discovery procedures,15 the majority of professional senti-
ment concedes that at this point in time there exists no foolproof 
analytical test or diagnosis that can identify the virus in a carrier.16 
A carrier need never have contracted the disease,17 yet he can carry 
the virus indefinitely18 and pass it to numerous recipients should he 
habitually give blood. Moreover, despite some indications pointing 
to the possibility of controlling the virus,19 it is acknowledged that 
there is no certain means of rendering the virus harmless or expung-
ing it from the blood, plasma, or serum that is to be transfused.20 
titis, •.. For serum hepatitis, active immunization of the general population may not 
be feasible even if a vaccine is developed, because of numerous practical problems." 
15. See generally TRANSFUSION, supra note 12; Bevan, Taswell 8e Gleich, Serum Im-
munoglobulin Leuels in Blood Donors Implicated in Transmission of Hepatitis, 203 
J.A.M.A. 38 (1968); Garibaldi, A New Look at Hospitals' Liability for Hepatitis Con-
taminated Blood on Principles of Strict Tort Liability, 48 CHICAGO B. RECORD 206 (1967); 
Weaver, King 8e Brown, A Clinical Evaluation of the "HIM" Test, 49 AM. J. CLINICAL 
p ,\THOLOGY 647 (1968). 
16, "Although many large efforts have been made to identify blood which has a 
high risk of transmitting hepatitis, there is still no proved method for identifying the 
hepatitis carriers." Walsh, Purcell, Morrow, Chanock 8e Schinidt, Posttransfusion Hepa-
titis After Open-Heart Operations, 211 J.A.M.A. 261, 265 (1970). This is not to say that 
no carrier can be identified. Some demonstrate an overt illness that would call for im• 
mediate disqualification, while others have abnormalities discoverable by means of liver 
function tests. See Mosley 8e Galambos, supra note 14, at 420. Estimates of detection 
rates range from 25 to 75%, Butterich 8e Wilson, supra note 9, at 70. One study states 
that 
the only laboratory screening test, currently available or proposed, that offers any 
promise of useful application by blood-banking and transfusion services in identi• 
fying the long-incubation [serum] form of hepatitis carriers is a test for the presence 
of Australia antigen in blood. 
Gocke 8e Kavey, Hepatitis Antigen, Correlation of Disease with Infectivity of Blood 
Donors, 1 THE LANCET 1055 (1969). The same study points out that at the current 
level of sensitivity, only about one-fourth of the cases can be detected by this means. 
All agree that there exists no certain method of identifying contaminated individuals. 
See, e.g., R. GRAY, supra note I, ,r 38.35; Mosley 8e Galambos, supra note 14, at 420; 
Wiener, supra note 12, at 1305. 
17, Mosley 8e Galambos, supra note 14, at 420; Wiener, supra note 12, at 1305. 
18, Wiener, supra note 11, at 1438. 
19, See, e.g., 279 NEW ENG, J. MED. 1290 (1968), where the director of a Red 
Cross Blood Program stated preliminary results from a Massachusetts survey indicated 
that by "packing" the red blood cells a much lower incidence of hepatitis was 
achieved. Other factors cited as possible Initigating influences are storage at room tem-
peratures over a period of several months and plasma irradiation. See R. GRAY, supra 
note 1, ,r 38.35. 
20. Butterich 8e Wilson, supra note 9, at 67 states: 
[B]lood products have been used in large quantities only during the last 30 years 
, • , [and] there has been a striking rise in the number of cases of serum hepatitis re-
ported yearly. Unlike diseases which are becoming more prevalent for unknown 
reasons, the increased incidence of serum hepatitis can be traced to epideiniologic 
factors which we simply have been unable thus far to control. 
Mosley 8e Galambos, supra note 14, at 429-30, further explains: 
The repeated attempts to find processes for inactivating the viruses of hepatitis in 
pooled plasma have been unavailing. Initially ultraviolet irradiation appeared to 
be effective as judged by the results of human volunteer experiments. Subsequent 
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Thus, although a hospital may be careful in its selection of donors 
and meticulous in its methods of storage and administration, it is 
still quite possible that a patient may contract hepatitis and perhaps 
die if he has been injected with hepatitis-infected blood. 
The lack of effective methods to discover and eliminate the 
virus makes it difficult for plaintiffs to prove a failure by hospitals 
to exercise reasonable diligence. Thus, attempts to hold hospitals 
liable for transfusions of hepatitis-contaminated blood based on a 
theory of negligence have been largely unsuccessful.21 The same want 
of preventive techniques renders a res ipsa loquitur assertion in-
effective. 22 A further obstacle encountered in some jurisdictions is 
the rule that the doctrine of respondeat superior cannot be used to 
hold a hospital liable for negligent harm inflicted by a physician or 
medical employee while rendering professional services.28 Finally, 
actions based on a theory of negligence per se24 or on the hospital's 
experience .•• has demonstrated that plasma so treated, at least under conditions 
of commercial porduction, still has a higher than average risk. Similarly, initial work 
with storage for 6 months at "room" temperature, or under more carefully con-
trolled conditions at 31.6° C (90° F), suggested that such material was safe, but a 
carefully controlled prospective investigation showed that this process was also in-
effective. Irradiated pooled plasma treated with betapropiolactone is reportedly 
safe, but the study has not been confirmed and the material is commercially un-
available. No effective method for sterilizing fibrinogen or anti-hemophilic globulin 
preparations is available. 
21. See, e.g., Fischer v. Wilmington Gen. Hosp. 51 Del. 554, 149 A.2d 749 (1959); 
Hiddy v. State, 207 Misc. 207, 137 N.Y.S.2d 334 (Ct. CI. 1955), afjd., 2 App. Div. 2d 644, 
151 N.Y.S.2d 621 (1956); Parker v. State, 201 Misc. 416, 105 N.Y.S.2d 735 (Ct. Cl. 1951), 
afjd., 280 App. Div. 157, 112 N.Y.S.2d 695, appeal denied, 280 App. Div. 901, 115 
N.Y.S.2d 311 (1952). 
22. Jackson v. Muhlenberg Hosp., 96 N.J. Super. 314, 232 A.2d 879 (L. 1967), revd, on 
other grounds, 53 N.J. 138, 249 A.2d 65 (1969). Since hepatitis can result from a blood 
transfusion notwithstanding the hospital's diligent efforts to prevent it, the fact that a 
patient contracted hepatitis is not sufficient to sustain the inference that someone was 
negligent, a necessary element for reliance on a res ipsa loquitur theory. See "\V. PROSSER, 
HANDBOOK OF THE LAw OF TORTS § 39, at 218-22 (3d ed. 1964). 
23. See Becker v. City of New York, 2 N.Y.2d 226, 232-33, 140 N.E.2d 262, 266, 159 
N.Y.S.2d 174, 180 (1957), in which the court stated: 
•.• [Al hospital ••• [is] immune from liability predicated on the doctrine of 
responaeat superior, when a patient at the hospital is injured as the result of a 
medical act performed by an employee of the hospital in the course of treating the 
patient •••. The rationale for ••• [this] is that the hospital employee when per-
forming a medical act is an independent contractor to the patient •••• The theory 
is that the hospital does not undertake to heal but merely to make healers avail-
able. 
See also Capasso v. Square Sanitarium, Inc., 3 Misc. 2d 273, 155 N.Y.S.2d 313 (Sup. Ct. 
1956); Lewis v. Columbus Hosp., 1 App. Div. 2d 444, 151 N.Y .S.2d 391 (1956). This rule, 
however, does not apply in other jurisdictions. See, e.g., National Homeopathic Hosp, 
v. Phillips, 181 F.2d 293 (D.C. Cir. 1950). 
24. See, e.g., Merck & Co. v. Kidd, 242 F.2d 592 (6th Cir. 1957) (transfusion of hepa-
titis-contaminated blood not a sale of a "filthy substance" within the meaning of the 
Tennessee Food, Drug and Cosmetic Act); Hoder v. Sayet, 196 S.2d 205 (Fla. Ct. App. 
1967) (not negligence per se for a hospital to purchase or obtain blood from commercial 
blood bank although such purchases may have increased the risk that the blood was 
contaminated). 
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failure to warn the patient of the dangers inherent in a transfusion25 
have not been successful. 
The lack of success in negligence suits prompted plaintiffs to 
base their actions on theories of implied warranty26 and strict Iiabil-
ity.27 However, a sale-service dichotomy that developed within the 
implied warranty doctrine28 generally proved fatal to plaintiffs' 
claims based on that theory.29 The sale-service dichotomy was first 
used to defeat a claim for damages resulting from a transfusion of 
hepatitis-infected blood in Perlmutter v. Beth David Hospital.30 
In that case, the defendant hospital had furnished blood for use 
in a transfusion. Plaintiff contracted serum hepatitis and sued the 
hospital for breach of implied warranty. Recovery was denied. 
The New York Court of Appeals reasoned that the contract between 
the plaintiff and the defendant hospital was essentially one for ser-
vices. Moreover, the contract was not divisible even though it pro-
vided that the hospital should supply certain "healing materials"31 
such as medicines, drugs, and even blood. The court concluded, there-
fore, that there was no sale to which an implied warranty could 
attach. 
Perlmutter has unquestionably been the most influential decision 
in this area of the law. Although often criticized32 and recently re-
25. Sloneker v. St. Joseph's Hosp., 233 F. Supp. 105 (D. Colo. 1964); Fischer v. 
Wilmington Gen. Hosp., 51 Del. 554, 149 A.2d 749 (1959). 
26. For a discussion of the development of the implied warranty theory, see ·w. 
PROSSER, supra note 22, § 97, at 678-81. 
27. For a discussion of the theory of strict liability, see ·w. PROSSER, supra note 22, 
§§ 74-79, at 506-44, § 87, at 672-85. It should be borne in mind that strict liability does 
not mean absolute liability. Under the latter theory, causation and harm alone furnish 
the basis for recovery. See Sweet v. State, 195 Misc. 494, 500-01, 89 N.Y.S.2d 506, 514 
(Ct. CI. 1949). Under strict liability, which is not founded upon negligence, there is 
still a dual requirement of (1) a defective product that is (2) unreasonably dangerous. 
See, e.g., REsrATEMENT § 402A; Wade, Strict Tort Liability of Manufacturers, 19 Sw. L.J. 
1, 13 (1965). 
28. The sale-service dichotomy is one of the contractural rules associated with im-
plied warranty that is criticized by W. PROSSER, supra note 22, § 95, at 655. Essentially, 
the sale-service rule states that implied warranties can only attach to a contract for the 
sale of products. Therefore, if the contract in any particular case is essentially one for 
services, there is no implied warranty. For e.xamples of the application of this dichot-
omy in areas other than blood transfusion cases, see Consolidated Timber Co. v. 
Womack, 132 F.2d 101 (9th Cir. 1942); Child's Dining Hall Co. v. Swingler, 173 Md. 
490, 197 A. 105 (1938); Pappanastos v. State Tax Commn., 235 Ala. 50, 177 S. 158 (1937). 
29. See cases cited in note 34 infra. 
30. 308 N.Y. 100, 123 N.E.2d 792 (1954). 
31. 308 N.Y. at 104, 123 N.E.2d at 794. 
32. See, e.g., Boland, Strict Liability in Tort for Transfusing Contaminated Blood, 
23 ARK. L. R.Ev. 236 (1969); Dunn, Blood Transfusions and Serum Hepatitis, 15 CLEV.-
MAR. L. R.Ev. 497 (1966); Haut &: Alter, Blood Transfusions-Strict Liability?, 43 ST. 
JOHN'S L. R.Ev. 557 (1969); Comment, Serum Hepatitis Through Blood Transfusions: A 
Wrong Without a Remedy?, 24 Sw. L.J. 305 (1970); Note, Warranties-Blood Transfu-
sions-Extension of Implied Warranties, 38 FORDHAM L. REv. 830 (1970); Note, Sales-
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jected in a few cases,33 it has provided the foundation for decisions 
in the majority of jurisdictions that have adjudicated the issue.H 
The Cunningham decision, however, may signify an end to that 
influence. The Illinois supreme court convincingly rejected the 
holding in Perlmutter that a transfusion of blood is a service rather 
than the sale of a product.35 Furthermore, since the Cunningham 
court deemed blood contaminated with hepatitis an unreasonably 
dangerous product, 36 a patient contracting the disease by transfusion 
or other injection may be virtually assured of success in a strict liabil-
ity action against the hospital. 37 
Blood Transfusions-Implied Warranties Under the Uniform Commercial Code, 46 
N.D. L. R.Ev. 367 (1970); Note, Blood Banks, Bad Blood, and Implied Warranty, 21 
U. MIAMI L. R.Ev. 479 (1966); Note, Sale-Implied Warranty-No Warranty in Blood 
Transfusion by Hospital, 37 NOTRE DAME LAW. 565 (1962); Note, Liability for Blood 
Transfusion Injuries, 42 MINN. L. R.Ev. 640 (1958); Note, Action for Breach of Implied 
Warranties of Quality Not Maintainable Against Hospital That Furnished Impure 
Blood to Patient, 69 HARV. L. R.Ev. 391 (1955); Note, Warranty-Implied Warranties of 
Quality Held Not Applicable to Blood Furnished by Hospital to Patient, 103 U. PA. 
L. R.Ev. 833 (1955); Note, Sales-Breach of Warranty-Supplying of Blood by Hospital 
Not a Sale, 29 ST. JoHN's L. R.Ev. 305 (1955). 
33. See Hoffman v. Misericordia Hosp., 439 Pa. 501, 267 A.2d 867 (1970), in which 
the court held that even if a transfusion could not be characterized as a "sale" the 
plaintiff could still recover on the basis of breach of implied warranty. See also Jackson 
v. Muhlenberg Hosp., 96 N.J. Super. 314, 232 A.2d 879 (L. 1967), revd. on other grounds, 
53 N.J. 138, 249 A.2d 65 (1969), in which the court held that a transfusion of human 
blood for consideration was a sale. A few courts, while denying claims based on a 
warranty running from the hospitals, have held that a warranty is properly assertable 
against commercial blood banks. See, e.g., Carter v. Inter-Faith Hosp., 60 :Misc. 2d 733, 
304 N.Y.S.2d 97 (Sup. Ct. 1969); Russell v. Community Blood Banlc, Inc., 185 S.2d 749 
(Fla. Ct. App. 1966). 
34. The following jurisdictions have indicated adherence to the Perlmutter rationale: 
Arizona: Whitehurst v. American Natl. Red Cross, 1 Ariz. App. 326, 402 P.2d 584 
(1965). 
Colorado: Sloneker v. St. Joseph's Hosp., 233 F. Supp. 105 (D. Colo. 1964). 
Connecticut: Epstein v. Giannattasio, 25 Conn. Supp. 109, 197 A.2d 842 (C.P. 1963) 
(dictum). 
Florida: White v. Sarasota County Pub. Hosp. Bd., 206 S.2d 19 (Fla. Ct. App. 1968). 
But see Russell v. Community Blood Banlc, Inc., 185 S.2d 749 (Fla. Ct. App. 1966). 
Georgia: Lovett v. Emory Univ., Inc., 116 Ga. App. 277, 156 S.E.2d 923 (1967). 
Minnesota: Balkowitsch v. Minneapolis War Memorial Blood Banlc, Inc., 270 Minn. 
151, 132 N.W .2d 805 (1965). 
Texas: Goelz v. J.K. &: Susie L. Wadeley Research Institute, 350 S.W .2d 573 
(Tex. Civ. App. 1961). (dictum). 
Utah: Dibblee v. Dr. W. H. Groves Latter-Day Saints Hosp., 12 Utah 2d 241, 
364 P.2d 1085 (1961). 
Washington: Gile v. Kennewick Pub. Hosp. Dist., 48 Wash. 2d 774, 296 P.2d 662 
(1956). 
Wisconsin: Koenig v. Milwaukee Blood Center, Inc., 23 Wis. 2d 324, 127 N.W .2d 
50 (1964). 
35. 47 Ill. 2d at 451-52, 266 N.E.2d at 900-02. 
36. 47 Ill. 2d at 456, 266 N.E.2d at 904. 
37. The REsTATEMENT § 402A would impose liability for the sale of an unreasonably 
dangerous product, and the court in Cunningham held that the transfusion of hepatitis-
infected blood is such a sale. Assumption of risk remains a valid defense to an action 
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The extent to which Cunningham will be accepted in other juris-
dictions is difficult to determine. Although Perlmutter undoubtedly 
continues to have considerable influence, Cunningham seems to be 
in accord with the growing disenchantment of some courts with the 
Perlmutter rationale38 as well as with what some commentators have 
been advocating for several years.39 Moreover, several states still have 
no statute or judicial ruling dealing with the issue,40 and Cunning-
ham may well be influential in those states that are disposed toward 
the view expressed in that case but are reluctant to effect the ground-
breaking themselves. 
On the other hand, several considerations tend to diminish the 
impact that Cunningham may have in other jurisdictions. Twenty-
three states have enacted statutes that specifically preserve the "ser-
vice" nature of blood transfusions.41 Since a sale is usually required 
brought under strict liability. See REsTATEMENT § 402A, comment n at 356. Comment n 
appears to limit the availability of the assumption of risk defense to cases in which 
the plaintiff " ••• discovers the defect and is aware of the danger, and nevertheless 
proceeds unreasonably to make use of the product." It is doubtful that a patient 
who is informed of both the need for a blood transfusion and the possibility of 
hepatitis virus in the blood to be used is acting unreasonably when he chooses to 
undergo the transfusion. 
38. See cases cited in note 33 supra. 
39. See authorities cited in note 32 supra. 
40. For states with a judicial ruling on point, see notes 33 & 34 supra. For states 
that have a statute dealing with the issue, see note 41 infra. 
41. See, e.g., CAL. HEALTH & SAFETY CODE § 1606 (West 1970), which provides: 
The procurement, processing, distribution, or use of whole blood, plasma, blood 
products, and blood derivatives for the purpose of injecting or transfusing the 
same • • • into the human body shall be construed to be • • • the rendition of a 
service by each and every person, firm, or corporation participating therein, and 
shall not be construed to be ••• a sale ••• for any purpose or purposes whatsoever. 
Other states that have enacted similar legislation include: 
Alabama: ALA. CODE tit. 7A, § 2-314(4) (Supp. 1969). 
Alaska: ALAsKA STAT. § 45.05.002 (1968). 
Arizona: .ARIZ. R.Ev. STAT. ANN. § 36-1151 (Supp. 1970). 
Arkansas: ARK. STAT. ANN. § 83-2-316(3)(d) (Supp. 1969). 
Delaware: DEL. CoDE ANN. tit. 5A, § 2-316(5) (1971). 
Louisiana: LA. Cxv. CODE ANN. art. 1764(B) (West Supp. 1968). 
Maine: ME. R.Ev. STAT. ANN. tit. 11, § 2-108 (Supp. 1969). 
Massachusetts: MAss. ANN. l.Aws ch. 106, § 2-316(5) (Supp. 1969). 
Miclxigan: MICH. STAT. ANN. § 14.528(1) (Supp. 1969). 
Mississippi: Miss. CoDE ANN. § 7129-71 (Supp. 1970). 
Nebraska: NEB. R.Ev. STAT. § 7129-4001 (Supp. 1969). 
Nevada: NEV. R.Ev. STAT. § 460.010 (1968). 
New Mexico: N.M. STAT. ANN. § 12-12-5 (Supp. 1969). 
North Dakota: N.D. CENT. CODE § 41-02-33(3)(d) (Supp. 1969). 
Oklahoma: OKLA. STAT. ANN. tit. 63 § 2151 (Supp. 1970). 
Oregon: ORE. R.Ev. STAT. § 97.300 (Supp. 1969). 
South Carolina: S.C. CoDE ANN. § 32-559 (Supp. 1970). 
South Dakota: S.D. CoMP. LAws ANN. § 57-4-33.1 (Supp. 1970). 
Tennessee: TENN. CoDE ANN. § 47-2-316 (Supp. 1970). 
Virginia: VA. CODE ANN. § 32-364.2 (1969). 
Wisconsin: WIS. STAT. ANN. § 146.31(2) (Supp. 1970). 
Wyoming: WYO. STAT. ANN. § 34-2-316(3)(d) (Supp. 1969). 
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to bring strict liability into play, 42 the effect of these statutes will be 
to preclude any strict liability cause of action.43 
In addition, the doctrine of sovereign immunity may exempt 
publicly supported hospitals from the Cunningham approach in 
many states.44 There are a great many exceptions to the sovereign 
immunity rule, however, and it cannot be assumed that the existence 
of the doctrine in any given state necessarily precludes recovery under 
the Cunningham analysis.45 Moreover, the courts have imposed a 
variety of limitations upon the sovereign immunity doctrine.46 
Furthermore, a court that is willing to accept the Cunningham analy-
sis may also be willing to re-evaluate the doctrine of sovereign im-
munity and hold ,it inapplicable to blood transfusion cases.47 Yet 
conceding all this, the fact that the doctrine of sovereign immunity 
remains the law in over half of the states48 implies that the applica-
tion of Cunningham will, in certain factual settings, thereby be 
impeded. 
A similar concept is the doctrine of charitable immunity, and 
in those states where it is the law it too will hinder application of 
a strict-liability theory to blood transfusion cases.49 Although the 
trend is clearly in the direction of disapproval50 and limitation111 
42. See note 6 supra. 
43. But there will be no such elimination when there is no requirement of a sale. 
See Hoffman v. Misericordia Hosp., 439 Pa. 501, 267 A.2d 867 (1970), discussed in note 
33 supra. 
44. For a discussion of sovereign immunity as a defense to tort claims, see 
W. PROSSER, supra note 22, § 125, at 1001-03, § 127, at 1019. 
45. For example, military, veterans, and public-service hospitals are subject to 
suit under the Federal Tort Claims Act, 28 U.S.C. §§ 1291, 1346, 1402, 1504, 2110, 2401-
02, 2411-12, 2671-80 (1964). The Act makes the United States liable for the wrong-
ful acts or omissions of federal employees within the scope of their employment 
"in the same manner and to the same extent as a private individual under like 
circumstances" under the local law of the place where the tort occurs. 28 U.S.C. § 2674 
(1964). 
There are some instances, however, when the Federal Tort Claims Act is not 
applicable-e.g., when the claim is based upon performance or failure to perform a 
discretionary function, or when it is based upon an intentional tort, or an act or 
omission of a governmental employee exercising due care in the execution of a statute 
or regulation. Members of the armed forces cannot recover when the alleged injury was 
incurred during active duty. See u. Prrrs. HEALTH LAW CENTER, PROBLEMS IN HOSPITAL 
LAW 151-52 (1968) [hereinafter HEALTH LAW CENTER]. 
46. For example, the hospital may have to be engaged in a "governmental" function 
as opposed to a "proprietary" one in order to qualify for the immunity. See generally 
HEALTH LAW CENTER, supra note 45, at 152-54; W. PROSSER, supra note 22, § 125, at 
1004-10. 
47. For an example of such a judicial re-evaluation that resulted in a holding 
that the doctrine does not protect public hospitals, see Muskopf v. Corning Hosp. 
Dist., 55 Cal. 2d 211, 359 P.2d 457, 11 Cal. Rptr. 89 (1961). 
48. I!EALTH LAW CENTER, supra note 45, at 152. An illustrative selection of cases is 
listed in Annot., 25 A.L.R.2d 203 (1952). 
49. For a discussion of the defense of charitable immunity to tort claims, see 
W. PROSSER, supra note 22, § 127, at 1019-24. 
50. "Where the question of [charitable immunity] has arisen as of first impression 
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of charitable immunity, the doctrine continues to possess sufficient 
vitality in some jurisdictions52 to thwart the assertion of a strict-li-
ability argument against charitable entities.53 
Perhaps the most significant of all the factors that will limit 
the influence of Cunningham is the analytical fragility of the court's 
reasoning. For though the court took a laudable step forward in 
discarding the Perlmutter rationale, in doing so it brushed aside 
a powerful objection to the application of strict liability with very 
questionable commentary. The basic objection to holding hospitals 
strictly liable for transfusions of hepatitis-infected blood is based on 
comment k to section 402A of the Restatement of Torts. Comment k 
excepts "unavoidably unsafe products" from the rule of strict lia-
bility. In order for a product to be unavoidably unsafe, three re-
quirements must be met: (I) all reasonable efforts must be made to 
make the product safe; (2) proper warnings of possible danger must 
be given; (3) experience must justify the marketing of the product 
despite the risk involved.54 The court added a fourth requirement, 
however: the product must not be impure.55 Since hepatitis-infected 
blood is by definition impure, the court held that it did not fall 
within the comment k exception. 
It is extremely difficult to justify the court's decision to read this 
additional requirement into comment k. Indeed, the language of 
comment k standing alone seems to refute thoroughly the court's 
analysis: 
... [A] product properly prepared, and accompanied by .proper 
directions and warning, is not defective, nor is it unreasonably dan-
gerous ... [when], because of lack of time and opportunity for 
sufficient medical experience, there can be no assurance of safety, 
or even perhaps of purity of ingredients, but such experience as 
there is justifies the marketing and use of the . . . [product] not-
withstanding a medically recognizable risk.56 
within recent years, it has been uniformly rejected; in no jurisdiction has the doctrine 
been adopted by overruling a prior judicial decision recognizing full liability." 
HEALm LAw CENTER, supra note 45, at 149. See also C. KRAMER, MEDICAL MALPRACTICE 
21-27 (rev. ed. 1965). W. PROSSER, supra note 22, § 127, at 1024, states that the doctrine 
"is clearly in full retreat." 
51. Even where the doctrine still exists, its vitality is often circumscribed by 
limitations placed upon it. See generally HEALTH LAw CENTER, supra note 45, at 143-48. 
52. For a jurisdiction-by-jurisdiction discussion of immunity rules and decisions, see 
Annot., 25 A.L.R.2d 29, 142-200 (1952). 
53. The determination whether a hospital can be characterized as charitable is 
occasionally troublesome. No perfect definition can be framed. See Annot., 7 A.L.R.3d 
1281, 1283 (1966). 
54. REsTATEMENT § 402A, comment k at 354. 
55. 47 lli. 2d at 456, 266 N.E.2d at 904. 
56. REsTATEMENT § 402A, comment k at 353-54 (former emphasis original, latter 
emphasis added). 
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Thus, comment k specifically applies to the situation in which medical 
knowledge cannot assure purity of ingredients but the use of the 
product is justified nonetheless. Notably, the court omitted the por-
tion relating to purity of ingredients from its quotation of comment 
k.51 
Moreover, the comment cites the Pasteur vaccine as an example 
of a product to which strict liability should not attach. The court 
distinguished the Pasteur vaccine from hepatitis-infected blood 
on the ground that the latter is an impure substance while the former 
is a pure substance. This distinction is factually questionable. The 
Pasteur vaccine is cultured in the brains of small laboratory animals 
such as rats, mice, and rabbits. Small particles of brain material 
are left in the vaccine and it is this brain material that causes harm 
to recipients of the vaccine.58 Thus, the Pasteur vaccine is not a 
"pure" substance; it contains particles of foreign material that oc-
casionally cause seric;ms harm to the recipient just as does hepatitis-
infected blood. This fact supports the conclusion that the court was 
engaged in a mere semantic exercise when it created the "pure-
impure" distinction. And in so doing, the court distorted the thrust 
of comment k. Comment k was intended to prevent the imposition 
of strict liablility when the value of a medical product outweighs 
its potential for causing harm by such a substantial degree that the 
use of the product is justified. 59 Therefore, in deciding whether 
the comment is applicable in any given situation, a court should 
determine only whether all reasonable efforts have been made to 
make the product safe and whether the necessity of administering 
the product outweighs an unavoidable element of risk to the patient. 
The fact that all medical efforts to remove the hepatitis virus from 
the blood have thus far been unsuccessful has already been docu-
mented. 60 And the necessity of blood transfusions in modern medicine 
appears to be substantially on a par with that of the Pasteur vac-
cine. 61 Therefore, it seems clear that the court erred in adding the 
57. 47 Ill. 2d at 456, 266 N.E.2d at 903-04. 
58. "All these vaccines [various rabies vaccines including the Pasteur vaccine] suffer 
from the presence of a large amount of foreign brain material which is capable of 
producing encephalitis and paralysis in a certain small proportion of individuals 
(1:4000 to 1:10,000)." Maccallum, Rabies, in VIRUS AND R.lCKEITSIAL DISEASFS OF MAN 
253, 261 (4th ed. 1967). 
59. See RESTATEMENT § 402A, comment k at 353-54, which justifies use of the Pasteur 
vaccine despite the great risk involved. 
60. See notes 15-20 supra and accompanying text. 
61. "The development of the modern blood transfusion in the past half-century is 
recognized by the medical profession as one of its finest achievements. Without today's 
blood transfusions many of the modern surgical practices would not be possible, and 
hemorrage would be a far greater cause of death." Note, 42 MINN. L. REV. 640, supra 
note 32. See also Trout, Blood Transfusions, 73 DICK. L. REv. 201, 212 (1969). 
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requirement that a product must be pure in order for comment k 
to apply.62 
The application of strict liability in any given situation has al-
ways rested heavily upon public-policy considerations. Although 
the court in Cunningham erroneously distinguished comment k, 
it was presumably free to reject the comment outright if it found 
sufficiently compelling reasons to do so. Therefore, an examination 
of the policy behind the application of strict liability to blood trans-
fusion cases is required before any conclusions can be reached con-
cerning the appropriateness of that doctrine for such cases. 
Several commentators have argued that comment k should not 
except contaminated-blood cases from the scope of Restatement sec-
tion 402A.63 The proposition most often asserted is that the financial 
consquences of a transfusion that results in hepatitis should be borne 
by hospitals because they are in the best position to insure them-
selves against the loss. Insurance premium costs could then be ab-
sorbed into the general overhead costs of the health centers. In this 
manner, the cost of a transfusion would be spread to all those who 
avail themselves of the hospitals' services in the form of higher 
hospital costs.64 Additionally, it has been argued that the imposition 
62. For a case agreeing that comment k applies to transfusions of impure blood, 
see Jackson v. Muhlenberg Hosp., 96 N.J. Super. 314, 232 A.2d 879 (L. 1967), revd. on 
other grounds, 53 N.J. 138, 249 A.2d 65 (1969). See also Note, Liability of a Hospital 
for,Supplying Unpure Blood, 1965 WIS. L. R.Ev. 374, 387-88. 
63. See, e.g., Comment, Serum Hepatitis Through Blood Transfusions: A Wrong 
Without a Remedy?, 24 Sw. L.J. 305 (1970); Comment, Strict Liability in Tort for 
Transfusing Contaminated Blood, 23 ARK. L. R.Ev. 236 (1969). 
64. Comment, 24 Sw. L.J. 305, supra note 63, at 321-25; Comment, 23 ARK. L. R.Ev. 
236, supra note 63, at 245-49. This is the loss-spreading system imposed in effect by 
Cunningham. It should be added that a secondary loss-spreading will occur among those 
people who have medical insurance. The rise in hospital costs would be followed by a 
rise in premium rates for medical insurance. However, it is difficult to rely on private 
medical insurance as a loss-spreading device because many person are simply not 
covered, often because of their financial status. J. BowER, E. CONNORS, J. MOSHER &: C. 
ROWLEY, HOSPITAL INCOME FLOW-A STUDY OF THE EFFECTS OF SOURCE OF PAYMENT ON 
HOSPITAL INCOME 48 (1970) [hereinafter HOSPITAL INCOME], demonstrate that payments 
from uninsured individuals account for approximately 15% of the payments received by 
hospitals from patients. This estimate was supported in an interview with John 
Zurgich, Associate Director of University Hospital, The University of Michigan, in 
Ann Arbor, Michigan, March 19, 1971 [hereinafter Zurgich Interview]. 
Moreover, even for the majority of patients who do have some type of protection, 
the coverage is often far from adequate. See, e.g., S. GREENBURG, THE TROUBLED CALLING 
132 (1965), in which the author states: 
fllnsurance pays 40 percent of the cost of surgery, 30 percent of the expenditures 
for the services of obstetricians, less than 10 percent of physicians' out of hospital 
fees, and little or nothing for other services and supplies. This means that in the 
course of a year, patients have to pay out of pocket an additional $2.5 billion for 
hospitalization, $3.5 billion for doctors' services, $3.9 billion for drugs and $4.5 
billion for other health services, such as dental care, nursing-home care, and appli-
ances •••• While medical costs have been going up at the rate of 5 to 10 percent 
a year, the ratio of such costs met by insurance has shown an average annual in-
crease of less than 2 percent. At the same time, insurance premium charges have 
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of strict liability would encourage a more rapid discovery of a cure 
for hepatitis or a means of detecting the virus in blood. 65 
The role of tort law as a loss distributor has grown dramatically 
in recent years. 66 In light of this development, it would seem anoma-
lous to allow a single, unfortunate patient to bear the costs that 
result from a treatment-a blood transfusion-to which all persons 
might be subjected. However, before the legal system imposes risk 
allocation in blood transfusion cases, several questions should be 
considered. How is this allocation to be achieved? Who should be 
included within it? Is the tort law the most effective medium for 
reaching the desired result? The decision in Cunningham can be 
used as a tool of analysis in answering these questions. 
As noted above, the result in Cunningham does effect some risk 
allocation.67 The court failed to point out, however, the severe 
drawbacks that this type of risk allocation entails. Of necessity, the 
hospitals' losses from some patients' contraction of post-transfusion 
hepatitis will be defrayed by increased assessments on all their pa-
tients. 68 This is true because, unlike most manufacturers and sellers 
who bear this type of business expense, health centers are not able 
to modify the blood's characteristics or abstain from selling it al-
together when the related financial responsibility becomes so onerous 
as to make its sale unprofitable. 69 Similarly, the losses suffered by 
commercial blood banks will be passed on primarily to hospital 
patients and others in need of blood.70 
been climbing "during the past decade at the rate of 10 percent a year under the 
impact of rising medical costs and increased utilization. 
Similarly, F. COOK, THE PLOT AGAINST THE PATIENT 231 (1967), notes that voluntary 
insurance has come to a "virtual dead end. • • • After nearly 40 years of trial, the 
only epitaph that can be written for the . • • program is that it is in no aspect 
satisfactory or even adequate." 
65. Comment, 24 Sw. L.J. 305, supra note 63, at 325; Comment, 23 ARK. L. REY. 
236, supra note 63, at 249. 
66. See generally J. FLEMING, AN INTRODUCTION TO THE LAW OF TORTS 1-24 (1967); 
Prosser, The Fall of the Citadel (Strict Liability to the Consumer), 50 MINN. L. REY. 
791 (1966). 
67. See note 64 supra and accompanying text. 
68. Predict Higher Patient Charges If Blood ls Treated as a Product, MODERN 
HosP., Nov. 1970, at 34. 
69. Once a hospital undertakes the care of a patient, of course, it might often be 
under a duty to give the patient blood, and the failure to do so would clearly give rise to 
an action based on negligence. See Church v. Adler, 350 Ill. App. 471, 113 N.E.2d 327 
(1953); Skeels v. Davidson, 18 Wash. 2d 358, 139 P .2d 301 (1943). 
70. Interview with Dr. Harold A. Oberman, Professor of Pathology and Medical 
Director of the Blood Bank, University of Michigan Medical School, Ann Arbor, 
Michigan, April 15, 1971 [hereinafter Oberman Interview]. Most hospitals purchase the 
majority of their blood supply from various types of blood banks. See generally 
CoMMI'ITEE ON PUBLIC HEALTfI, HUMAN BLOOD IN NEW YORK CITY-A STUDY IN !TS 
PROCUREMENT, DISTRIBUTION AND UTILIZATION (1958). Therefore, increased costs resulting 
from the imposition of strict liability on blood banks will be passed on to patients 
through the hospitals when the blood is resold. 
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The precise economic impact of this type of loss-spreading is 
not entirely clear. In some cases the cost of blood alone will be 
affected, but it seems probable that in many others the increased 
costs will be allocated among all medical services provided by the 
hospital.71 If this is the case, the resulting increase in already 
rapidly rising medical costs72 could be very substantial.73 Further-
more, if the Cunningham theory of strict liability in blood trans-
fusion cases were to be applied to analogous situations such as organ 
transplants,74 the economic impact would be even more severe. And 
as medical costs rise, health care will be placed further beyond the 
reach of those persons in lower income brackets. 
This economic burden on the poor is also a factor that distin-
guishes the strict liability imposed in Cunningham from that im-
posed by the courts in other product liability cases. An increase 
71. Higher blood prices resulting from an imposition of liability on commercial 
blood banks will often be reflected only in the price of blood. At the University of 
Michigan Hospital, for example, it was estimated that the increased cost of blood 
derived from external sources would be reflected solely in the price charged for blood. 
On the other hand, if the hospital itself were held liable for hepatitis infection re-
sulting from its own blood supply, those costs would be distributed among all products 
and services sold by the hospital. Moreover, some private insurers are considering the 
cancellation of hospital liability insurance entirely, apparently because of the unpre-
dictable possibility of large recoveries. Should this happen, many hospitals and their 
patients might face an even more serious economic problem. Oberman Interview, supra 
note 70. 
72. See Presidential Prescription for Health, TIME, March 1, 1971, at 11, in which 
it is stated that since 1960 the average daily cost of hospitalization has risen from 
$56 to $144. The nation's total health bill has reached $70 billion, more than double 
that of a decade ago. This now averages $324 per person per year. See also Walsh, 
Medical Care: As Costs Soar, Support Grows for Major Reform, 166 SCIENCE 1126 (1969); 
Crisis Ahead in Medical Care, U.S. NEWS & WoRLD REP., Feb. 26, 1968, at 56; The 
$60-Billion Crisis over Medical Care, BUSINESS WEEK, Jan. 17, 1970, at 50. 
73. There can be no precise estimate of the increase in medical cost resulting from 
the imposition of liability for transfusing a vitiated serum. However, since "[s]ome 2.5 
million hospital patients are transfused annually," F. CooK, supra note 64, at 157, 
and the incidence of infection may be around 3%, with 30,000 serious cases and up to 
3,000 deaths per year (see note 12 supra), the recoveries could well be enough to increase 
significantly the costs of hospitalization. This is particularly true in light of the fact 
that awards may well exceed the $50,000 asked for by Mrs. Cunningham in the principal 
case. With this in mind, it has been predicted that for a 400-bed hospital an average 
$14 per patient-per day increase would result from the holding in Cunningham. See 
MODERN HosP., supra note 68, at 35. Since hospital income is based primarily on 
the number of patient-days it has (Zurgich Interview, supra note 64) the smaller 
hospitals would experience even larger increases, and notably there is less patient in-
surance coverage in the rural health centers that have fewer beds than do other centers. 
See HOSPITAL INCOME, supra note 64, at 25. 
One concrete example of how Cunningham has affected blood-drawing institutions 
can be seen in the rise in insurance rates for a Chicago area blood bank, which ex-
perienced a twenty-fold increase in annual premiums ($1,500 to $30,000) following the 
decision. Letter from Nathan Smith, Executive Director of the Midwest Chapter of 
the National Hemophilia Foundation, to Richard French, of Howard & French, 
Chicago, Ill., Feb. 23, 1971. This increased insurance premium will almost certainly 
be reflected in an increased cost of blood coming from the Chicago area blood banks. 
74. See notes 80-82 infra and accompanying text. 
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in the cost of automobiles, candy bars, or even canned meat that 
results from the imposition of strict liability on the manufacturer 
of these items does not have the effect of making a necessity of life 
less available to financially disadvantaged persons. It is submitted 
that the inability of hospitals to prevent the occurrence of hepatitis 
coupled with this potential economic impact on the poor renders 
application of strict liability in tort far less appropriate when 
hepatitis-infected blood is sold than when ordinary consumer goods 
are sold. The most desirable result would be to alleviate a recipient's 
financial burden without substantially increasing the costs of medical 
care in general. The most obvious way to achieve this result would 
be to distribute the expenses associated with transfusion-contracted 
hepatitis among the population as a whole. Since everyone is sus-
ceptible to disease and accident, and, correspondingly, the necessity 
of receiving blood, it is not a harsh result to expect all persons to 
bear a portion of the expense. The imposition of strict liability 
on hospitals will spread the costs primarily to the purchasers of 
hospitalization rather than to the public at large and therefore can-
not achieve this result.75 
Another drawback to the Cunningham method of risk allocation 
is that recovery is predicated upon litigation, or at least the threat 
of litigation, against the hospital. This procedure inevitably suffers 
from the economic disadvantages that attorney and court fees dimin-
ish a plaintiff's recovery and insurance company profits increase 
the costs of providing the protection.76 Moreover, since the poor are 
generally less aware of their rights and less able to litigate,77 they 
are the least likely to be compensated for their losses. Additionally, 
as noted above, several states continue to hold some hospitals free 
from tort liability on the grounds of sovereign and charitable im-
munity. 78 In these states, some patients-again often the most needy 
-will be left without a remedy if the hospital provides its own blood 
supply.79 Thus by raising medical costs and implementing a system 
75. See notes 70-73 supra and accompanying text. It should be noted that some 
secondary loss-spreading among persons other than purchasers of hospitalization is 
inevitable. For example, medical insurance rates will probably increase as the cost of 
medical products rises; hence all policy holders will be affected whether or not they ac-
tually go to the hospital. Some insurance costs may, in turn, be passed on to the 
customers of those who purchase the insurance. This secondary loss-spreading, however, 
is extremely speculative and difficult to measure, and in any event will not be complete 
loss-spreading since the burden will not fall equally on all people. 
76. With respect to some of the obstacles in seeking judicially-imposed solutions in 
today's courts, see What's Wrong with the Courts: The Chief Justice Speaks Out, 
U.S. NEWS & WORLD REP., Aug. 24, 1970, at 68. 
77. See generally Note, Litigation Costs: The Hidden Barrier to the Indigent, 56 
GEO. L.J. 516 (1968). 
78. See notes 44-53 supra and accompanying text. 
79. If the blood is supplied by a commercial blood bank, however, charitable and 
sovereign immunity would not bar an action against the blood bank. See note !Ill supra. 
May 1971] Recent Developments 1187 
of risk allocation that will be least accessible to the poor, Cunning-
ham gives the least protection to those persons who need it most. 
Furthermore, Cunningham may have ramifications in areas of 
medicine other than the transfusion of blood. For example, if a 
hospital were to have a patient badly in need of a kidney transplant 
and the kidney used in the transplant was undetectably diseased, 
the hospital might well be liable to the patient for any resulting 
harm. 80 This would be so notwithstanding the fact that the hospital 
was providing the best possible treatment and the patient's life was 
extended several years as a result of the operation. Since in many 
instances the organs capable of being transplanted have grossly un-
detectable deficiencies,81 the extension of strict liability to such situa-
tions could have the dual effect of further raising hospital costs and 
reducing the available supply of transplant organs.82 Indeed, the 
Cunningham analysis could be applied to medicines, anesthetics, and 
practically any curative implement containing a hidden defect that 
can be classified as an impurity. 
Finally, the hastening of medical triumphs is not a necessary 
or even probable consequence of the Cunningham result. Although 
product safety is without doubt a result toward which the imposi-
tion of strict liability is directed,83 the influence of such liability is 
questionable when the item sold is virtually unimprovable due to 
the lack of requisite information and techniques. It seems quite 
unlikely that the growth of medical knowledge will be quickened 
by making hospitals guarantors of the purity of substances not yet 
fully understood. Medical science seems to be making ample pro-
gress without the imposition of artificial economic stimuli.84 And 
there is evidence that the Cunningham result will promote the 
80. Other areas of transplants that could conceivably be affected include removable 
and built-in prostheses and artificial organs, as well as homotransplants (from either 
living humans or cadavers) and heterotransplants (from animal to man), Mouzas, The 
Present State of Organ Transplantation, 46 INTI.. SURGERY 370 (1966); and the thymus, 
Transplanting the Thymus, 2 THE LANCET 1226 (1968). 
81. Oberman Interview, supra note 70. 
82. It is quite likely that hospitals, wary of being held liable for hepatitis and 
related injurious elements or defects, would establish certain rules or guidelines that 
would tend to make blood and other materials less readily available. Zurgich Interview, 
supra note 64. 
83. See Escola v. Coca Cola Bottling Co., 24 Cal. 2d 453, 462, 150 P .2d 436, 440-41 
(1944) Gustice Tra}nor, concurring): 
Public policy demands that responsibility be fixed wherever it will most 
effectively reduce the hazards to life and health inherent in defective products 
that reach the market •••• It is to the public's interest to discourage the marketing 
of products having defects. 
84. See, e.g., The Wall St. J., March 2, 1971, at 23, col. 1 (midwest ed.), which reports 
several of the efforts of individual researchers and such organizations as the National 
Research Council, the Division of Biologics Standards of the National Institutes of 
Health, the American Red Cross, and the American Association of Blood Banks. 
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spending of funds by medical groups to effect the legislative repeal 
of that case rather than to find a cure for hepatitis.85 
None of the above drawbacks were discussed or even mentioned 
by the court in Cunningham. The court seemed to assume that its 
decision to impose strict liability on hospitals would yield a socially 
desirable result.86 But as this Recent Development has attempted 
to demonstrate, the reverse may well be true. Admittedly, the 
Cunningham approach avoids the imposition of a staggering financial 
burden upon a single, unfortunate patient. However, this result has 
been achieved through a method of risk allocation that lacks effi-
ciency, fails to provide protection for all persons who are in need 
of it, and leads to further increases in the cost of medical care. 
Essentially, a greater diffusion of the costs attributable to the un-
controllable effects of proper medical care is needed; but, as pointed 
out above, the tort law cannot achieve this goal. It is submitted, 
therefore, that any decision concerning the allocation of risks for 
unavoidable medical accidents would more appropriately be made 
by a legislative body. Thorough committee investigations would 
enable a legislature to gain a more complete understanding of all 
the potential ramifications involved in spreading the costs of unavoid-
able medical accidents than the limited context of litigation will 
allow. Therefore, a legislature would be in a much better position 
to make practical and informed judgments about who should re-
ceive the needed protection, what products should be covered, and 
what the financial limits of the protection should be. 
It should be recognized that a legislative approach at the state 
level would probably be impractical because, in order to achieve 
nationwide loss-spreading, all fifty states would have to enact vir-
tually identical statutes. However, several major proposals for an 
extensive health care program have already been made at the federal 
level.87 There appears to be no reason why a provision for the type 
85. In fact, the outgrowth of Cunningham in Illinois has been precisely such a 
lobbying effort. Noting that several states provide legislation to prohibit blood being 
termed a "sale" (see note 41 supra), the Illinois Medical Society and the Illinois 
Hospital Association both urged immediate enactment of statutes to counter the deci-
sion. .AMERICAN MEDICAL NEWs, Oct. 12, 1970, at 3, col. I. Several commentators have 
opined that this reaction would be typical in any state that adopts the Cunningham 
analysis. Zurgich Interview, supra note 64; AMERICAN MEDICAL NEWS, supra; The Wall 
St. J., March 2, 1971, at 23, col. I (midwest ed.). 
86. See 47 Ill. 2d at 457, 266 N.E.2d at 904, for the court's analysis of the economic 
arguments made against the imposition of strict liability. 
87. Six major proposals have been formulated. 
Senator Edward Kennedy's proposal would provide federally financed comprehensive 
health benefits, without cost sharing, for all United States citizens and residents, with 
the present exclusion of adult dental care and with limitations placed upon the pur-
chase of drugs, treatment in nursing homes, and mental health care. There would be 
minimum cost to the lowest income earners, and up to $315 per year charged to those 
earning in excess of $15,000. S. 3, 92d Cong., 1st Sess. (1971). See 117 CONG. R.Ec. S. 109 
(daily ed. Jan. 25, 1971). 
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of situation involved in Cunningham could not be included in any 
proposal that is ultimately enacted. Such a legislative approach would 
not necessarily be a perfect one, but it would be far superior to piece-
meal judicial attempts to stretch established standards of responsi-
bility beyond the range of their application and effectiveness. 
President Nixon's plan would expand and almost entirely replace the present 
medicaid program. Families on welfare and those in the lowest incomes would have 
their premiums paid by the Government, while other working poor would pay on a 
basis scaled upward as income rises. In addition, there would be possible coverage for 
all persons with "catastrophic" illnesses, i.e., situations involving extremely costly treat-
ments or incapacitations for relatively long durations. S. 1623, 92d Cong., 1st Sess. (1971). 
See 117 CONG. REc. s. 1496, H. 77'! (daily ed. Feb. 18, 1971). 
The Aetna Life 8: Casualty proposal, one receiving wide backing from the insurance 
industry, would provide for the poor and uninsurable to elect minimum benefits 
through private insurance, with the Government paying the premiums. This would in-
clude ambulatory and institutional care, with catastrophic medical expenses gradually 
being extended to all, starting with the poor. H.R. 4349, 92d Cong., 1st Sess. (1971). See 
117 CONG. REc. S. 1958 (daily ed. Feb. 25, 1971). 
The American Medical Association-backed Fulton-Broyhill bill would be based upon 
taxation credits and offered on a voluntary basis. Free coverage would be provided for 
those persons paying $300 or less income tax, while others would be allowed a graded 
scale of tax credits running from 98% ($301 income tax) to 10% (when taxes exceed 
$1,300). Minimum benefits would include medical services, hospitalization up to sixty 
days, and optional benefits including coverage for catastrophic illnesses. H.R. 4960-63, 
92d Cong., 1st Sess. (1971). See 117 CONG. REc. S. 1957-58 {daily ed. Feb. 25, 1971). 
Senator Jacob Javits' bill would expand medicare's hospitalization and medical 
benefits. Coverage would eventually be provided for all with a minimal cost for the 
lowest income earners and up to $495 annually for those earning in excess of $15,000. 
S. 836, 92d Cong., 1st Sess. (1971). See 117 CONG. REc. S. 1959 (daily ed. Feb. 25, 1971). 
Congresswoman Martha Griffiths' bill, supported by the AFL-CIO, calls for com-
prehensive health benefits to all persons residing in the United States for a year or 
more, 11,ith minimal cost to the lowest income earners and a maximum annual cost 
in any instance of $50 per individual and $100 per family. H.R. 22, 92d Cong., 1st Sess. 
(1971). See 117 CONG. REc. H. 197 (daily ed. Jan. 26, 1971). 
See generally National Health Insurance: The Next Attack on Medical Costs, 
CHANGING TIMES, Jan. 1971, at 41; The Push Is on for Added Federal Health Aids, 
U.S. NEWS 8: WORLD REP., Feb. 8, 1971, at 35-6. 
The scope of this Recent Development does not include a comparison of the relative 
merits of these programs. However, it is urged that the proposal finally adopted should 
include provisions to insure adequate recompense for patients who contract hepatitis 
unavoidably or who suffer any other deleterious effects from the proper administration 
of modern medical therapy. Presently, because private insurance often furnishes only 
partial coverage (see note 64 supra), it appears that the Kennedy and Griffiths proposals 
would be the most amenable to this end. 
